HCWB Revenue second quarter 2026 Y/Y Growth Comment
Hcw Biologics Inc achieved in the second quarter 2026, above Company average Revenue surge of 2472.98% year on year, to $ 0.26 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 155 other companies have achieved higher Revenue growth. While Hcw Biologics Inc ' s Revenue doubling of 2472.98% ranks overall at the positon no. 3423 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Hcw Biologics Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
24223.42 %
1423.86 %
-100 %
(Mar 31 2026)
HCWB's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Hcw Biologics Inc disclosed fall in Revenue from the first quarter by -96.07% to $ 0.26 millions, from $ 6.54 millions achived in the previous reporting period.
Within Major Pharmaceutical Preparations industry 210 other companies have achieved higher Revenue quarter on quarter growth. While Hcw Biologics Inc 's Revenue growth quarter on quarter, overall rank is 3819.
In the II. Quarter 2026 Hcw Biologics Inc disclosed fall in Revenue from the first quarter by -96.07% to $ 0.26 millions, from $ 6.54 millions achived in the previous reporting period.
Within Major Pharmaceutical Preparations industry 210 other companies have achieved higher Revenue quarter on quarter growth. While Hcw Biologics Inc 's Revenue growth quarter on quarter, overall rank is 3819.
Hcw Biologics Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 6.84
$ 6.59
$ 0.05
$ 0.42
$ 0.83
Y / Y Revenue Growth (TTM)
721.62 %
356.15 %
-97.89 %
-86.87 %
-77.13 %
Year on Year Revenue Growth Overall
Ranking
# 3522
# 1048
# 2206
# 1822
# 3353
Seqeuential Revenue Change (TTM)
3.8 %
12081.56 %
-87.18 %
-49.33 %
-42.37 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 3423
# 2827
# 1911
# 206
# 2833
Cumulative Revenue growth Comment
With 721.62% annual Revenue growth, Hcw Biologics Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.
In the Healthcare sector 504 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1048 to 3522.
With 721.62% annual Revenue growth, Hcw Biologics Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.
In the Healthcare sector 504 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1048 to 3522.
About Hcw Biologics Inc Revenue Growth Rates (HCWB), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
3,828.21%